Assistant Professor, Department of Medicine, Division of Medical Oncology
Recognitions
Chief Fellow, University of Colorado
(2023)
Publications
Arora N, Eule C, Gupta A, Li HC, Sadeghi N. Clinicopathologic features, management, and outcomes of plasmablastic lymphoma: A 10-year experience. Am J Hematol. 2019 May;94(5):E127-E129. PubMed PMID: 30734351
Eule C, Arora N, Li HC, Sadeghi N. Presentation and management of primary mediastinal large B-cell lymphoma: a retrospective cohort analysis. Acta Oncol. 2020 Jul;59(7):786-788. PubMed PMID: 32233823
Eule C, Bhulani N, Paulk E, Rhodes R, Beg MS. Characteristics and impact of the most-cited palliative oncology studies from 1995 to 2016. BMC Cancer. 2018 Dec 22;18(1):1281. PubMed PMID: 30577766
Eule C, Gupta A, Nagalla S. The Direct Antiglobulin Test for Evaluating Anemia. JAMA. 2018 Dec 25;320(24):2593-2594. PubMed PMID: 30508030
Eule CJ, Flaig TW, Wong K, Graf R, Lam ET. Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):188-193. PubMed PMID: 36402814
Eule CJ, Hu J, Al-Saad S, Collier K, Boland P, Lewis AR, McKay RR, Narayan V, Bosse D, Mortazavi A, Rose TL, Costello BA, Bryce AH, Lam ET. Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study. Clin Genitourin Cancer. 2023 Aug;21(4):483-490. PubMed PMID: 37193610
Keshvani N, Gupta A, Eule C, Sadeghi N. Sacral bone cyst treatment resulting in paraplegia. BMJ Case Rep. 2018 Jan 18;2018. PubMed PMID: 29351944
Kessler ER, Callihan E, Hu J, Eule C, Srivastava G, Kemme DJ, Iruku P, Rana V, Moore J, Schuster SR, Amirault M, Flaig TW, Lam ET. A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer Res Commun. 2023 Jun;3(6):1004-1012. PubMed PMID: 37377613